- Home
- Publications
- Publication Search
- Publication Details
Title
Towards treatments for silicosis
Authors
Keywords
-
Journal
CURRENT OPINION IN PULMONARY MEDICINE
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-18
DOI
10.1097/mcp.0000000000001020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crystalline silica-induced macrophage pyroptosis interacting with mitophagy contributes to pulmonary fibrosis via modulating mitochondria homeostasis
- (2023) Yungeng Wei et al. JOURNAL OF HAZARDOUS MATERIALS
- Herbal Compounds in the Treatment of Pulmonary Silicosis
- (2022) J ADAMCAKOVA et al. PHYSIOLOGICAL RESEARCH
- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2022) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Another One Fights the Dust: Targeting the NLRP3 Inflammasome for the Treatment of Silicosis
- (2022) Maggie Lam et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China
- (2022) Hua Quan et al. Frontiers in Medicine
- Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review
- (2022) Vanessa Marques Da Silva et al. Nanomaterials
- The Regulation and Modification of GSDMD Signaling in Diseases
- (2022) Zihao Li et al. Frontiers in Immunology
- Evaluation of Oxidative Stress Parameters and Genotoxic Effects in Patients with Work-Related Asthma and Silicosis
- (2022) Ozlem Kar Kurt et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Clinical usefulness of serum angiotensin converting enzyme in silicosis
- (2022) J. Blanco-Pérez et al. Pulmonology
- Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
- (2022) Anna J. Podolanczuk et al. BMC Pulmonary Medicine
- Blocking Caspase-1/Gsdmd and Caspase-3/-8/Gsdme pyroptotic pathways rescues silicosis in mice
- (2022) Lulu Kang et al. PLoS Genetics
- Macrophage Autophagy and Silicosis: Current Perspective and Latest Insights
- (2021) Shiyi Tan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis
- (2021) Jana Adamcakova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gasdermin D mediates the maturation and release of IL-1α downstream of inflammasomes
- (2021) Kohsuke Tsuchiya et al. Cell Reports
- Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases
- (2021) Bowen Zhou et al. Cell Reports
- Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A
- (2021) Zhu-jie Cao et al. ACTA PHARMACOLOGICA SINICA
- Loop Between NLRP3 Inflammasome and Reactive Oxygen Species
- (2021) Abishai Dominic et al. ANTIOXIDANTS & REDOX SIGNALING
- Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
- (2021) Sarah E. Corcoran et al. PHARMACOLOGICAL REVIEWS
- Serum levels of inflammatory mediators as prognostic biomarker in silica exposed workers
- (2021) José Jesús Blanco-Pérez et al. Scientific Reports
- Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway
- (2021) Shu-xian Li et al. Frontiers in Pharmacology
- Dying cells fan the flames of inflammation
- (2021) Kim Newton et al. SCIENCE
- Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis
- (2021) Meiyue Song et al. Acta Pharmaceutica Sinica B
- Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
- (2020) Saleela M Ruwanpura et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- To protect or adversely affect? The dichotomous role of the NLRP1 inflammasome in human disease
- (2020) Juselyn D. Tupik et al. MOLECULAR ASPECTS OF MEDICINE
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017
- (2020) Peng Shi et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Artificial Stone Silicosis
- (2020) Antonio León-Jiménez et al. CHEST
- Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
- (2020) Anita A. Pinar et al. Frontiers in Pharmacology
- Intranasal Flunisolide Suppresses Pathological Alterations Caused by Silica Particles in the Lungs of Mice
- (2020) Tatiana Paula Teixeira Ferreira et al. Frontiers in Endocrinology
- Inflammasome activation and regulation: toward a better understanding of complex mechanisms
- (2020) Danping Zheng et al. Cell Discovery
- Crystalline silica activates the T-cell and the B-cell antigen receptor complexes and induces T-cell and B-cell proliferation
- (2019) Theodoros Eleftheriadis et al. AUTOIMMUNITY
- Carvedilol attenuates experimentally induced silicosis in rats via modulation of P-AKT/mTOR/TGFβ1 signaling
- (2019) Manar Gamal Helal et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis
- (2019) Huaping Huang et al. BIOSCIENCE REPORTS
- Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection
- (2019) Sarah Rosli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prevention of crystalline silica-induced inflammation by the anti-malarial hydroxychloroquine
- (2019) Rachel Burmeister et al. INHALATION TOXICOLOGY
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
- (2019) Kevin R. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Gasdermin-D pore acts as a conduit for IL-1β secretion in mice
- (2018) Rosalie Heilig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells
- (2018) Xiang Li et al. EXPERIMENTAL CELL RESEARCH
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases
- (2018) Maggie Lam et al. PHARMACOLOGY & THERAPEUTICS
- Interleukin-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice
- (2018) Naoya Sugimoto et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
- (2018) Chad A. Newton et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model
- (2018) Jingwen Guo et al. TOXICOLOGY LETTERS
- Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares
- (2017) Rose Soskind et al. EXPERT OPINION ON PHARMACOTHERAPY
- Interleukin-17 Is Required for Control of Chronic Lung Infection Caused by Pseudomonas aeruginosa
- (2016) Hannah K. Bayes et al. INFECTION AND IMMUNITY
- Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
- (2016) Fernanda Ferreira Cruz et al. PLoS One
- Treating Pulmonary Silicosis by Blocking Interleukin 1
- (2015) Giulio Cavalli et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
- (2015) Wan-ting He et al. CELL RESEARCH
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases
- (2015) Mutlay Sayan et al. Particle and Fibre Toxicology
- Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway
- (2015) Yubei Qu et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Th17 can regulate silica-induced lung inflammation through an IL-1β-dependent mechanism
- (2014) Laiyu Song et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- State of the Art: Imaging of Occupational Lung Disease
- (2014) Christian W. Cox et al. RADIOLOGY
- Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice
- (2013) Jiali Guo et al. ARCHIVES OF TOXICOLOGY
- Relaxin attenuates silica-induced pulmonary fibrosis by regulating collagen type I and MMP-2
- (2013) Xiao-Feng Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Treating inflammation by blocking interleukin-1 in humans
- (2013) Charles A. Dinarello et al. SEMINARS IN IMMUNOLOGY
- Artificial Stone Silicosis
- (2012) Mordechai R. Kramer et al. CHEST
- Current status of inflammasome blockers as anti-inflammatory drugs
- (2012) Gloria López-Castejón et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues
- (2012) Virginia Hernández–Gea et al. GASTROENTEROLOGY
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
- (2009) Yeonseok Chung et al. IMMUNITY
- Induction of Systemic Lupus Erythematosus with Tumor Necrosis Factor Blockers
- (2009) E. SOFORO et al. JOURNAL OF RHEUMATOLOGY
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- The Nalp3 inflammasome is essential for the development of silicosis
- (2008) Suzanne L. Cassel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search